216 related articles for article (PubMed ID: 17168720)
1. Anti-galectin compounds as potential anti-cancer drugs.
Ingrassia L; Camby I; Lefranc F; Mathieu V; Nshimyumukiza P; Darro F; Kiss R
Curr Med Chem; 2006; 13(29):3513-27. PubMed ID: 17168720
[TBL] [Abstract][Full Text] [Related]
2. Galectins: novel anti-inflammatory drug targets.
Liu FT
Expert Opin Ther Targets; 2002 Aug; 6(4):461-8. PubMed ID: 16353421
[TBL] [Abstract][Full Text] [Related]
3. [Galectins, a class of unconventional lectins].
Advedissian T; Deshayes F; Poirier F; Grandjean C; Viguier M
Med Sci (Paris); 2015 May; 31(5):499-505. PubMed ID: 26059300
[TBL] [Abstract][Full Text] [Related]
4. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
Vladoiu MC; Labrie M; St-Pierre Y
Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
[TBL] [Abstract][Full Text] [Related]
5. Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.
Metz C; Döger R; Riquelme E; Cortés P; Holmes C; Shaughnessy R; Oyanadel C; Grabowski C; González A; Soza A
Biol Res; 2016 Jul; 49(1):33. PubMed ID: 27459991
[TBL] [Abstract][Full Text] [Related]
6. Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.
Vladoiu MC; Labrie M; Létourneau M; Egesborg P; Gagné D; Billard É; Grosset AA; Doucet N; Chatenet D; St-Pierre Y
Oncotarget; 2015 Dec; 6(38):40970-80. PubMed ID: 26543238
[TBL] [Abstract][Full Text] [Related]
7. The role of galectins in the initiation, amplification and resolution of the inflammatory response.
Rubinstein N; Ilarregui JM; Toscano MA; Rabinovich GA
Tissue Antigens; 2004 Jul; 64(1):1-12. PubMed ID: 15191517
[TBL] [Abstract][Full Text] [Related]
8. Galectins and gliomas.
Le Mercier M; Fortin S; Mathieu V; Kiss R; Lefranc F
Brain Pathol; 2010 Jan; 20(1):17-27. PubMed ID: 19371355
[TBL] [Abstract][Full Text] [Related]
9. The role of galectin-3 in cancer drug resistance.
Fukumori T; Kanayama HO; Raz A
Drug Resist Updat; 2007 Jun; 10(3):101-8. PubMed ID: 17544840
[TBL] [Abstract][Full Text] [Related]
10. Galectins in apoptosis.
Hsu DK; Yang RY; Liu FT
Methods Enzymol; 2006; 417():256-73. PubMed ID: 17132510
[TBL] [Abstract][Full Text] [Related]
11. Galectin-7 in Epithelial Homeostasis and Carcinomas.
Advedissian T; Deshayes F; Viguier M
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257082
[TBL] [Abstract][Full Text] [Related]
12. The role of galectins in colorectal cancer progression.
Barrow H; Rhodes JM; Yu LG
Int J Cancer; 2011 Jul; 129(1):1-8. PubMed ID: 21520033
[TBL] [Abstract][Full Text] [Related]
13. Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.
Wdowiak K; Francuz T; Gallego-Colon E; Ruiz-Agamez N; Kubeczko M; Grochoła I; Wojnar J
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320431
[TBL] [Abstract][Full Text] [Related]
14. Tumor galectinology: insights into the complex network of a family of endogenous lectins.
Lahm H; André S; Hoeflich A; Kaltner H; Siebert HC; Sordat B; von der Lieth CW; Wolf E; Gabius HJ
Glycoconj J; 2004; 20(4):227-38. PubMed ID: 15115907
[TBL] [Abstract][Full Text] [Related]
15. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
16. [Galectins in hematological malignancies--role, functions and potential therapeutic targets].
Wdowiak K; Spychałowicz W; Fajkis M; Wojnar J
Postepy Hig Med Dosw (Online); 2016 Feb; 70():95-103. PubMed ID: 26943306
[TBL] [Abstract][Full Text] [Related]
17. Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.
Compagno D; Gentilini LD; Jaworski FM; Pérez IG; Contrufo G; Laderach DJ
Glycobiology; 2014 Oct; 24(10):899-906. PubMed ID: 24939371
[TBL] [Abstract][Full Text] [Related]
18. Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis.
Rabinovich GA; Cumashi A; Bianco GA; Ciavardelli D; Iurisci I; D'Egidio M; Piccolo E; Tinari N; Nifantiev N; Iacobelli S
Glycobiology; 2006 Mar; 16(3):210-20. PubMed ID: 16282605
[TBL] [Abstract][Full Text] [Related]
19. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
20. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development.
Dussouy C; Kishor C; Lambert A; Lamoureux C; Blanchard H; Grandjean C
Chem Biol Drug Des; 2020 Oct; 96(4):1123-1133. PubMed ID: 32220037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]